Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sten Fredrikson

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Medical Economics|April 6, 2013
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in SwedenSten Fredrikson, Euan McLeod, Nathaniel Henry, et al.
The Cochrane Database of Systematic Reviews|April 26, 2017
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosisGraziella Filippini, Cinzia Del Giovane, Marinella Clerico, et al.
Lakartidningen|July 30, 2004
[A national curriculum in neurology for medical education]Arne Lindgren, Tor Ansved, Sten-Magnus Aquilonius, et al.
CNS Drugs|November 25, 2016
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis ExpertsThomas Berger, Irina Elovaara, Sten Fredrikson, et al.
Neuroradiology|September 24, 2009
A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI imagesJuha Martola, Jakob Bergström, Sten Fredrikson, et al.
Lakartidningen|October 4, 2008
[Changing neurology--from diagnostic to therapeutic discipline]Anja Smits, Gunnar Andsberg, Peter M Andersen, et al.
Lakartidningen|June 28, 2012
[The Swedish Neurological Association: The number of neurologists need to double over the next decade]Ingela Nilsson Remahl, Sten Fredrikson, Martin Gunnarsson, et al.
Lakartidningen|October 4, 2008
[Representantives of the Swedish Neurological Association: Swedish neurology needs strong resource reinforcement]Anja Smits, Peter M Andersen, Magnus Andersson, et al.
Annals of Neurology|February 15, 2020
Validation of Rapid Magnetic Resonance Myelin Imaging in Multiple SclerosisRussell Ouellette, Gabriel Mangeat, Ildiko Polyak, et al.
Clinical Therapeutics|May 1, 2012
Cost-effectiveness analysis of interferon beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosisJohn P Caloyeras, Bin Zhang, Cheng Wang, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Medical Economics|April 6, 2013
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in SwedenSten Fredrikson, Euan McLeod, Nathaniel Henry, et al.
The Cochrane Database of Systematic Reviews|April 26, 2017
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosisGraziella Filippini, Cinzia Del Giovane, Marinella Clerico, et al.
Lakartidningen|July 30, 2004
[A national curriculum in neurology for medical education]Arne Lindgren, Tor Ansved, Sten-Magnus Aquilonius, et al.
CNS Drugs|November 25, 2016
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis ExpertsThomas Berger, Irina Elovaara, Sten Fredrikson, et al.
Neuroradiology|September 24, 2009
A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI imagesJuha Martola, Jakob Bergström, Sten Fredrikson, et al.
Lakartidningen|October 4, 2008
[Changing neurology--from diagnostic to therapeutic discipline]Anja Smits, Gunnar Andsberg, Peter M Andersen, et al.
Lakartidningen|June 28, 2012
[The Swedish Neurological Association: The number of neurologists need to double over the next decade]Ingela Nilsson Remahl, Sten Fredrikson, Martin Gunnarsson, et al.
Lakartidningen|October 4, 2008
[Representantives of the Swedish Neurological Association: Swedish neurology needs strong resource reinforcement]Anja Smits, Peter M Andersen, Magnus Andersson, et al.
Annals of Neurology|February 15, 2020
Validation of Rapid Magnetic Resonance Myelin Imaging in Multiple SclerosisRussell Ouellette, Gabriel Mangeat, Ildiko Polyak, et al.
Clinical Therapeutics|May 1, 2012
Cost-effectiveness analysis of interferon beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosisJohn P Caloyeras, Bin Zhang, Cheng Wang, et al.
Pageof 7